Hossein Maghsoudi

Dr. Hossein Maghsoudi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
HMHossein Maghsoudi
Hossein Maghsoudi
Farhad SheikhniaFarhad Sheikhnia
Farhad Sheikhnia
Przemyslaw SitarekPrzemyslaw Sitarek
Przemyslaw Sitarek
NHNooshin Hajmalek
Nooshin Hajmalek
SHSepideh Hassani
Sepideh Hassani
Tomasz KowalczykTomasz Kowalczyk
Tomasz Kowalczyk
Prostate cancer (PC) is the second most common type of cancer and the leading cause of death among men worldwide. Preventing the progression of cancer after treatments such as radical prostatectomy, radiation therapy, and hormone therapy is a major concern faced by prostate cancer patients. Inflammation, which can be caused by various factors such as infections, the microbiome, obesity and a high-fat diet, is considered to be the main cause of PC. Inflammatory cells are believed to play a crucial role in tumor progression. Therefore, nonsteroidal anti-inflammatory drugs along with their effects on the treatment of inflammation-related diseases, can prevent cancer and its progression by suppressing various inflammatory pathways. Recent evidence shows that nonsteroidal anti-inflammatory drugs are effective in the prevention and treatment of prostate cancer. In this review, we discuss the different pathways through which these drugs exert their potential preventive and therapeutic effects on prostate cancer.